Tang Capital Management LLC Coherus Bio Sciences, Inc. Transaction History
Tang Capital Management LLC
- $2.2 Billion
- Q3 2025
A detailed history of Tang Capital Management LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 5,097,362 shares of CHRS stock, worth $6.07 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
5,097,362
Previous 5,097,362
-0.0%
Holding current value
$6.07 Million
Previous $3.72 Million
124.64%
% of portfolio
0.38%
Previous 0.22%
Shares
11 transactions
Others Institutions Holding CHRS
# of Institutions
125Shares Held
54.7MCall Options Held
291KPut Options Held
120K-
Black Rock Inc. New York, NY11.8MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$12.3 Million0.0% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.61 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA2.74MShares$3.26 Million0.0% of portfolio
-
State Street Corp Boston, MA2.22MShares$2.65 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $92.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...